Market Access World USA 2011 - the world's most comprehensive policy review forum

Chip Davis
PhRMA

Thomas L. Johnson
MHPA

Eric Klein
Eli Lilly

Michael Lauer
NIH

Steve Phillips
J&J

Antje Behring
GBA

Andres Pichon Riviere
IECS

Jasmine Pwu
Center for Drug Evaluation

Arnold Van Halteren
CVZ

Ed Schoonveld
ZS Associates

event sponsors

Market Access World USA 2011 follows a highly successful series of market access events and will focus on US reform against an international backdrop.

How new reimbursement models will impact market access
How CER will differ from EU HTA experience
What is the role of real life/observational studies in the future security of market access
HTA agency policy and practice globally: comparing and contrasting different models
Risk sharing, value based pricing, pay for performance
Quality improvement measures

You’ll come away with great new ideas to do better business.

Register for Market Access World USA 2011 »
Download Brochure »

To showcase their latest services to their target audience
To meet and do business with senior Market Access professionals
To position their brand as a leader within the pharmaceutical & biotech market
To generate leads, meet prospects and do business

This is the single most important market access event you can attend this year.

New drug pricing systems – including risk sharing agreements
The use of independent Health Technology Assessment Agencies to provide guidance on new treatments
The use of comparative effectiveness studies to assess drugs

If you need to know the latest innovations in these areas you must attend.
Register now »

If you wish to access senior marketers in the pharma industry you need to be here. There are limited sponsorship opportunities.
Download Brochure »